On September 24, the Food and Drug Administration (FDA) convened a public advisory committee meeting to discuss safety concerns about the Essure – a permanent birth control device that is implanted in ...
MOUNTAIN VIEW, Calif., Sept. 13, 2010 (GLOBE NEWSWIRE) -- Conceptus Inc. (Nasdaq:CPTS), developer of the Essure (R) procedure, the most effective non-surgical permanent birth control method available, ...
MOUNTAIN VIEW, Calif., May 2, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure ® procedure, the most effective permanent birth control method available, today introduced ...
Federal regulators said they will hold a public meeting to "discuss scientific data regarding Essure’s safety and effectiveness," a review that comes after the I-Team uncovered inconsistencies in a ...
ST. LOUIS (KSDK) – Thursday was a day of often emotional testimony over a controversial birth control device. Women from the St. Louis area and across the country are urging the FDA to take Essure off ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results